Summary report on the graded prognostic assessment: an accurate and facile diagnosis-specific tool to estimate survival for patients with brain metastases.
By P. Sperduto, N. Kased, D. Roberge, Zhiyuan Xu, R. Shanley, Xianghua Luo, P. Sneed, S. Chao, R. Weil, J. Suh and 12 more. Journal of Clinical Oncology, 2012
1,331 citations recorded by the source corpus.
Subfields: Oncology, Pulmonary and Respiratory Medicine
View Paper: https://www.semanticscholar.org/paper/ec35da92f6d7764264b90357f38a17eafcbe258c
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Oncology
Citations in the corpus
- Estimating Survival in Patients With Lung Cancer and Brain Metastases: An Update of the Graded Prognostic Assessment for Lung Cancer Using Molecular Markers (Lung-molGPA) (2017, background): “8 months.(10) Our group has recently published a study on the effect of gene alterations on survival in patients with lung cancer and brain metastases that was based on a multi-institutional retrospective database.”
- Hippocampal Avoidance During Whole-Brain Radiotherapy Plus Memantine for Patients With Brain Metastases: Phase III Trial NRG Oncology CC001. (2020, background): “To aid in decision making, prognostic systems have been developed to provide survival time estimates for patients with brain metastases.(29) Given the potential for symptoms and impaired function from uncontrolled brain metastases, one of the intents of brain metastases management is palliation thro”
- Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. (2018, methodology): “Prognosis can be estimated based on the Radiation Therapy Oncology Group recursive partitioning analysis (RPA): class I patients are those< 65 years old, with a good PS [Karnofsky Index (KI) 70%], no other extracranial metastases and a controlled primary tumour; class III patients have a KI < 70%; a”
- Appraisal of the Karnofsky Performance Status and proposal of a simple algorithmic system for its evaluation (2013, background): “In the last thirty years various studies have demonstrated the prognostic value of the KPS, primarily for various cancers [10-13], but also for other disease entities [14].”